RTW Biotech Opportunities Ltd (RTW)
LSE
2.54
-0.04 (-1.55%)
Real-time Data
07:00 AM
Day's Range
2.512.61
52 wk Range
1.392.64
Financial Statements - RTW - RTW Biotech Opportunities Ltd
Revenue
250.88M▲ 547.8%
Net Income
245.19M▲ 617.4%Net Margin 97.7%
Free Cash Flow
105.25M▲ 184.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 250.88M | 38.72M | 86.29M | -36.50M | -60.91M | 162.77M |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 245.19M | 34.17M | 83.19M | -39.43M | -64.34M | 160.65M |
| Income Tax | - | - | - | - | - | - |
| Net Income | 245.19M | 34.17M | 83.19M | -39.43M | -64.34M | 160.65M |
| EPS Basic | 0.63 | 0.11 | 0.36 | -0.17 | -0.27 | 0.67 |
| EPS Diluted | 0.63 | 0.11 | 0.36 | -0.17 | -0.27 | 0.67 |
| Basic Shares Outstanding | 389.19M | 310.72M | 231.08M | 231.98M | 238.31M | 239.78M |
| Diluted Shares Outstanding | 389.19M | 310.72M | 231.08M | 231.98M | 238.31M | 239.78M |
| Ebit | - | - | - | - | - | - |
| Ebitda | - | - | - | - | - | - |
| Net Income Continuous Operations | 245.19M | 34.17M | 83.19M | -39.43M | -64.34M | 160.65M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
